Chronic Obstructive Pulmonary Disease Moderate
12
1
1
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
17%
2 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (12)
Respiratory and Cardiovascular Alterations in Patients With Chronic Obstructive Pulmonary Disease
Chest Mobility Exercises Versus Proprioceptive Neuromuscular Facilitation in Patients With COPD
Association of Cathelicidin and Vitamin D Levels With the Category and Course of COPD
Mesenchymal Stem Cells for The Treatment of Chronic Obstructive Pulmonary Disease
Observational Study of the Wellinks Solution Impact on Quality of Life and Clinical Outcomes in Patients With COPD
Effect of NMES on Quadriceps Muscle Strength and Endurance in Patients With COPD
Manual Therapy in Addition to Pulmonary Rehabilitation in Moderate Chronic Obstructive Pulmonary Disease.
Aerosol Therapy in Obese COPD Patients.
The Effects of RPL554 in Addition to Tiotropium in COPD Patients
Effect Of Ketamine Infusion In Patients With COPD Applied One Lung Ventilation
Beetroot Juice - Effects on Performance in Chronic Obstructive Pulmonary Disease Patients
The Study of CCTM and Common Diseases